Industry 11 / 13
Compounding Pharmacy Engineering.
Controlled environments designed around preparation, containment, workflow and operational readiness.

What Is a Compounding Facility?
A compounding facility is where medications are prepared for specific patients or uses rather than produced in large commercial batches. One facility may combine non-sterile preparation, sterile compounding and hazardous drug handling, together with the storage, washing, quality control, packing and waste areas that support them.
Each of these activities protects something different: the preparation, the operator, the surroundings or all three. ALVEDA engineers the rooms, routes and systems so that each activity keeps its own logic, from zoning and pressure relationships to HVAC, utilities and the evidence needed to show the facility performs as intended.
Three preparation types
One facility, three kinds of protection.
- 01
Non-Sterile Compounding
Oral liquids, creams, ointments, capsules and similar preparations. The environment is built around clear separation, dust control at weighing, cleanable finishes and dedicated washing, with the need for any classified space confirmed per project.
- Separation from dispensing, storage and office areas
- Weighing and powder handling with local containment
- Water quality for preparation and washing
- Equipment washing and drying area
- Cleanable finishes and controlled access
- Material and waste routes that keep clean and used items apart
- 02
Sterile Compounding
Preparations that must remain free of viable microorganisms. The environment depends on a controlled sequence of rooms, gowning, filtered air, pressure relationships and primary engineering controls, each with a defined role in protecting the preparation.
- Classification concept agreed with the quality team
- Ante room and gowning sequence
- Pressure cascade and airflow direction
- PEC, pass box and material transfer interfaces
- Sterilization and aseptic filling interfaces where required
- Environmental monitoring and qualification readiness
- 03
Hazardous Drug Compounding
Preparations involving drugs that can harm personnel or the surroundings. The engineering logic shifts toward containment along the full journey of the material, from receipt and unpacking to compounding, decontamination and waste dispatch.
- Dedicated receiving, unpacking and segregated storage
- Containment PECs and rooms held negative where required
- Exhaust strategy and separation from other air systems
- PPE donning and doffing, and access control
- Deactivation, decontamination and spill response provisions
- Segregated hazardous waste route, holding and dispatch
How the facility works
How a Compounding Facility Works.
A facility can be read as a sequence of functional zones. The grouping below is illustrative; the actual rooms, adjacencies and boundaries are defined per project from the preparations, volumes and site.
ALV-CPF-01
Compounding facility — engineering map
An original conceptual plan organised in nine functional zones. Switch layers to read classification, pressure, air handling, flows and utilities; select a room for its engineering considerations.
Zone-level view — select a zone below
Select a zone to see its rooms.
L-00 OVERVIEW
Overview
Nine functional zones arranged so that people, materials and waste each follow their own route, and hazardous work is contained in its own suite.
- Public / front
- Personnel transition
- Material logistics
- Non-sterile compounding
- Non-hazardous sterile compounding
- Hazardous compounding
- QC / microbiology
- Output
- Waste
Showing the Overview layer
- AZone
Public / Front
Keeps visitors and administrative activity outside the controlled areas.
Reception · Prescription intake · Dispensing counter · Offices
- BZone
Personnel Transition
Moves people between cleanliness levels through a defined sequence.
Changing rooms · Gowning · Hand hygiene · Degowning
- CZone
Material Logistics
Controls how materials arrive, wait for release and enter preparation areas.
Receiving · Quarantine · Storage · Cold storage · Material airlock
- DZone
Non-Sterile Compounding
Separates powder handling, preparation and washing from other activities.
Weighing · Compounding room · Equipment washing · Packing
- EZone
Non-Hazardous Sterile Compounding
Protects sterile preparations through a controlled room sequence.
Ante room · Buffer room · PEC area · Pass box
- FZone
Hazardous Compounding
Contains hazardous drugs while still protecting the preparation.
Hazardous storage · Hazardous ante room · Hazardous buffer room · Containment PEC
- GZone
QC / Microbiology
Supports release and monitoring without sharing air or routes with preparation.
QC laboratory · Microbiology · Sterility testing · Media storage
- HZone
Output
Moves finished preparations out without crossing incoming materials.
Inspection · Labeling · Final packing · Dispatch
- IZone
Waste
Gives waste its own route to collection and dispatch.
General waste · Hazardous waste hold · Decontamination · Waste dispatch
CONCEPTUAL FACILITY DIAGRAM — FOR ILLUSTRATIVE PURPOSES ONLYFinal classifications depend on process requirements, risk assessment and applicable project requirements.
Pressure, containment & flow
How people, materials and air move through the suite.
Pressure concept explorer
Pick a room to see what its pressure relationship is meant to achieve, and which way air moves across its doors.
B-06
PositiveRelative relationships only — pressure values are set per project.
Corridor
- Room function
- Controlled circulation linking gowning, suite ante rooms, QC sample transfer and output.
- Classification concept
- ISO 8 concept, NON-HD
- Containment objective
- Keep unclassified air away from every suite entrance.
- Relative pressure strategy
- Reference level of the cascade: positive to changing and unclassified spaces, lower than the sterile ante rooms that open onto it.
- Adjacent spaces
- First gowning, degowning, sterile and hazardous ante rooms, sample transfer.
- Monitoring requirement (conceptual)
- Differential pressure indication at key doors and periodic non-viable particle checks.
Sterile compounding journey
Materials and people reach the sterile room by parallel routes that never share a door. Select a step to see what the facility has to provide.
MATMaterial track
PERSPersonnel gowning track
MAT
Material entry
Released materials and components are staged for the sterile suite.
Engineering focus
- Only released, labelled items move forward
- Outer packaging removed before the controlled boundary
- Quantities limited to the planned work
Conceptual rooms
C-02C-03C-04
Happening alongside
Conceptual sequence — the actual steps follow each project’s process and risk assessment.
Hazardous compounding journey
Eight stages a hazardous drug passes through in a compounding facility. Select a stage to see its facility, containment and personnel considerations.
01 / 08
Receive
Hazardous deliveries are identified at the point of receipt and kept apart from general goods.
Conceptual rooms
C-01C-02
FACFacility
- Defined receiving position for hazardous items
- Short, direct link to hazardous storage
CONContainment
- Outer packaging kept closed
- Spill kit at the point of receipt
PERPersonnel
- Trained receiving staff only
- Handling PPE defined for receipt
Engineering illustration — not medical or regulatory advice.
Engineering challenges
Engineering Challenges We Address Early.
- 01
ChallengeCrossing personnel and material routes
Routes are mapped from receipt to dispatch before rooms are fixed, so each movement has a defined path and transition point.
- 02
ChallengeUnclear cleanroom zoning
A classification concept is developed with the quality team and tied to the function of each room.
- 03
ChallengePoor pressure relationships
Pressure relationships are set from the protection or containment objective of each boundary, then planned for monitoring and verification.
- 04
ChallengeHazardous and non-hazardous activities mixed
Hazardous activities receive their own rooms, routes and containment measures, separated from non-hazardous work.
- 05
ChallengeShared HVAC without adequate segregation
AHU zones are grouped by activity, cleanliness and containment need, with exhaust arranged to keep segregation intact.
- 06
ChallengeMissing water and utility strategy
Water, compressed air and other utilities are defined per use point, with only the systems the facility actually needs.
- 07
ChallengeWeak waste route
Waste is given its own route, holding area and dispatch point, separated from clean corridors.
- 08
ChallengeInsufficient monitoring strategy
Monitoring parameters and point locations are proposed with the facility design, so instruments and data have a place from the start.
- 09
ChallengeIncomplete qualification evidence
Requirements are traced to test evidence through a CQV readiness matrix agreed with the project team.
- 10
ChallengePoor future maintainability
Service access, filter replacement and equipment removal are considered in the layout so maintenance does not compromise controlled areas.
Quality control & laboratories
Laboratories Designed Around Workflow and Control.
ALVEDA provides facility and engineering support for laboratories. ALVEDA does not perform laboratory testing.
- 01
QC analytical laboratory
Benches, fume extraction and utilities planned around the analytical methods in use.
- 02
Microbiology support
Separated from chemistry and from preparation air systems.
- 03
Sterility testing environment
A controlled environment with its own entry and gowning route.
- 04
BET / endotoxin testing area
Space and services arranged for bacterial endotoxin testing where required.
- 05
Sample flow
Samples move from receipt to testing without crossing waste.
- 06
Media / chemical storage
Controlled storage for media, reagents and chemicals.
- 07
Washing
Glassware and equipment washing separated from clean storage.
- 08
Waste handling
Decontamination before disposal and a defined exit route.
Existing facilities
Upgrading an Existing Compounding Facility?
- 01
Gap assessment
Current layout, routes and systems reviewed against the confirmed requirements.
- 02
Layout reconfiguration
Rooms and routes rearranged to remove crossings.
- 03
Cleanroom upgrade
Envelope, finishes, airlocks and pass boxes brought in line with the new concept.
- 04
HVAC upgrade
Zoning, filtration and exhaust revised around the activities served.
- 05
Containment upgrade
Hazardous areas given the segregation and containment they need.
- 06
Water / utility upgrade
Water and utility systems reviewed per use point.
- 07
Monitoring upgrade
Monitoring points, instruments and data handling revised.
- 08
Qualification readiness
Requalification planned for every change that affects qualified systems.
- 09
Phased implementation
Works sequenced around ongoing operation where possible.
Connected engineering
The disciplines behind a compounding facility.
- 04Cleanroom DesignClassified spaces with defined pressure cascades, airlocks and gowning sequences.
- 05HVAC EngineeringAir systems designed for cleanliness, pressure, temperature and humidity control.
- 13Pharmaceutical Water & Clean Utility SystemsPretreatment, generation, storage and distribution engineered as one coordinated water system.
- 06Process UtilitiesSteam, air, gases, water and drainage systems sized and specified for regulated production.
- 07GMP & ComplianceFacility design reviewed against GMP requirements at every stage.
- 08Qualification & Validation (CQV)Documented evidence that facilities, utilities and equipment perform as intended.
- 18Facility Upgrades & RetrofitExpansions, upgrades and retrofits engineered around the facility that is already running.
- 26QC & Microbiology Laboratory EngineeringAnalytical and microbiology laboratories planned around their workflows, environments and utilities.
- 09Project ManagementOne point of control for scope, cost, schedule and interfaces.
It is a facility where medications are prepared for specific patients or uses, rather than manufactured in large commercial batches. Depending on the preparations involved, it can include non-sterile compounding rooms, sterile compounding suites, hazardous drug areas and supporting spaces for storage, washing, quality control, packing and waste. From an engineering perspective, the facility is a set of rooms, routes and systems that must work together around each type of preparation.
Sterile compounding prepares medications that must remain free of viable microorganisms, so it typically relies on a controlled sequence of classified rooms, gowning, filtered air, pressure relationships and primary engineering controls. Non-sterile compounding covers preparations such as oral liquids, creams or capsules; it still needs clear separation, cleanable finishes, dust control and dedicated washing, but it does not always require classified cleanrooms. The environment each facility needs is defined per project from the preparations and the applicable requirements.
The facility must protect personnel and the surroundings as well as the preparation. That usually shifts the engineering toward containment: dedicated receiving and unpacking, segregated storage, containment primary engineering controls, rooms held at negative pressure where required, exhaust strategy, PPE donning and doffing, decontamination provisions and a separate waste route. The exact measures depend on the drugs, dosage forms and activities in each project.
Most contamination and containment problems start where routes cross: clean materials meeting used items, people moving between areas of different cleanliness without a defined transition, or waste leaving through a clean corridor. Planning these routes first, from receipt to dispatch and disposal, allows the room layout, airlocks, pass boxes and pressure relationships to support the intended workflow instead of working against it.
Pressure relationships set the direction in which air moves between rooms. Where the priority is protecting the preparation, air generally moves from cleaner to less clean spaces; where the priority is containing a hazardous drug, rooms are typically held negative so that air moves inward. The relationships and the differential values are defined per project from the room functions, risk assessment and applicable requirements, then monitored and verified.
Not necessarily. It depends on the type of preparation, the jurisdiction and the project. Sterile compounding typically involves classified environments, while many non-sterile activities can be carried out in controlled, cleanable rooms without a cleanroom classification. The appropriate environment for each activity is confirmed with the client and the relevant requirements during the early design stages.
HVAC zones follow the activities, not only the floor plan. Rooms are grouped by cleanliness, containment needs, pressure regime, temperature and humidity requirements and operating hours, so that areas with conflicting needs, such as hazardous and non-hazardous compounding or laboratories and preparation rooms, are not served in a way that compromises segregation. Supply, return, exhaust and filtration are then developed for each zone.
Depending on the preparations and equipment, utilities may include pharmaceutical water for preparation and washing, compressed air, clean steam where sterilization equipment requires it, drainage designed to avoid contamination, and power continuity for critical systems. Not every facility needs every utility; the list is defined per use point during design.
CQV stands for commissioning, qualification and validation. Commissioning confirms that systems such as HVAC, monitoring and utilities are installed and working; qualification documents that rooms, equipment and systems meet their defined requirements; and validation shows that the processes perform consistently. ALVEDA supports planning and documentation of this path; the scope and the parties executing each activity are agreed per project.
Yes. An upgrade usually starts with a gap assessment of the current layout, routes, pressure relationships, HVAC, utilities and monitoring against the confirmed requirements, followed by a prioritized engineering response and a phased implementation plan that considers ongoing operation and requalification.
Next step
Planning a pharmaceutical project?
Share the product type, the current stage and the main constraints. We will respond with a proposed scope and next steps.
+20 101 171 1700